Teclison, Inc. to Participate in ASCO Gastrointestinal Cancers Symposium
PRINCETON, N. J., Jan. 06, 2026 (GLOBE NEWSWIRE) — Teclison, Inc., a clinical-stage oncology company dedicated to advancing immunotherapeutic treatments for solid tumors, today announced that Ray Lee, chief executive officer and co-founder of Teclison will participate in the ASCO Gastrointestinal Cancers Symposium on January 9th. ASCO Gastrointestinal Cancers Symposium Date: Friday, January 9, 2026 […]